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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a group of pathogenic bacterial
strains resistant to a class of antibiotics that is a major cause for concern in health care systems.
There is a lack of study in whether health care centers are reservoirs for these bacteria, especially
within developed countries. Five environmental swab samples were collected from five different
university health care centers across the region, and 16 swab samples from a general university
environment. Any isolated bacterial strains collected underwent five biochemical tests (mannitol
fermentation, DNase activity, oxidase activity, catalase activity, and coagulase activity) to
preliminarily identify S. aureus bacteria. 24% of the clinical samples and 25% of environmental
samples contained S. aureus, signifying an equal distribution of the species among the two
location groups. In addition, extensive literature review showed how isolated S. aureus strains
can easily be characterized as MRSA, through antibiotic disc-diffusion testing and genetic
sequencing of the potential SCCmec region. This genetic sequencing can also identify SCCmec
type and class, identifiers useful in comparison to current MRSA studies.
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Introduction
Staphylococcus aureus is a species of bacteria known to cause infection, primarily through
its introduction into, and incubation within, an open wound. This bacterial species was one of the
earliest to be heavily studied in the medical community, largely due in part to its susceptibility to
penicillin. However, greater exposure and treatment with these newly discovered antibiotics
allowed S. aureus to quickly acquire antibiotic resistance (Centers for Disease Control and
Prevention, 2020). Antibiotic resistance is a phenomenon in which the few bacteria resistant to
the specific therapy can survive and multiply after treatment. The resistant bacteria can then
cause disease in a new patient, who cannot be treated with the same antibiotic or therapy as the
first patient. Over time, all new infections from that bacterial species will be immune to a specific
therapy.
As a result of increasing antibiotic resistance, S. aureus quickly became resistant to the
first commercially viable antibiotic, penicillin, by the 1940s, and to the antibiotic’s subsequent
synthetic alternative, methicillin, by the 1970s (National Institute of Allergy and Infectious
Disease, 2016). These strains which are resistant to β-lactams, the antibiotic family of methicillin
and penicillin, are known as methicillin-resistant Staphylococcus aureus (MRSA). Recently,
extensive studies have shown that an increasing number of MRSA strains are showing resistance
to a more aggressive antibiotic, vancomycin, highlighting the increasing resistance of these
pathogens (Hasan, Acharjee, & Noor, 2016). Understanding whether or not these bacteria are
present in health care treatment centers, along with their characteristics, will allow medical staff
to prepare for, and combat, the growing wave of antibiotic resistance.
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In traditional healthcare settings, bacterial infections are primarily transmitted through
direct contact, such as touching a contaminated surface (fomite) and then immediately touching
an open wound. Other routes of infection include close contact or quarters with areas soiled by
human waste (Center for Health Protection, 2017). MRSA can cause severe infections, such as
bacteremia, sepsis, pneumonia, and even death. Even with the initiatives to prevent
transmission, MRSA infections are persistent in healthcare settings.
Current MRSA Studies
One large area in which MRSA samples are analyzed from environmental sources are
livestock animal populations. S. aureus has been shown to infect humans through ingestion of
animal products (meat, poultry, dairy, etc.), but only in rare cases. Animals are mainly used as a
sample population to investigate the effects of antibiotic therapies on S. aureus. Giacinti et al.
(2017) isolated MRSA in dairy sheep from farms in central Italy. The researchers found that while
the S. aureus presence in the samples collected was high (53.3%), only 0.7% of samples had
MRSA. While the bacteria have been shown to transmit illness through livestock and their
subsequent dairy, meat, or poultry products, the most common and lethal method of
transmission is through contamination in healthcare centers. (Centers for Disease Control and
Prevention, 2017)
Another large area of study with the MRSA bacteria is in antibiotic resistance testing using
samples from patients, often directly collected from the wounds of patients. These wound
isolation studies are primarily done to test the effectiveness of new antibiotic therapies. One
recent example of this type of study, performed in Turkey, used samples from patients diagnosed
with and treated for MRSA. The researchers were using the patient isolates to test the efficacy
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of a new antibiotic, clindamycin (Gul et al., 2008). The researchers found that 64.1% of the
isolates were resistant to clindamycin, and that 84.9% were resistant to erythromycin, an
antibiotic of the same class.
A third, and least common, type of study involving MRSA utilizes environmental isolates
collected from hospitals. Abdolmaleki, Mashak, and Dehkordi (2019) isolated MRSA from
cockroaches captured in hospitals, both from skin scrapings and from gut dissections. After
isolation for MRSA, the bacteria were characterized phenotypically and genotypically to observe
the defining characteristics within the strains analyzed. They concluded that a high prevalence of
MRSA was found, which were largely resistant to a multitude of antibiotics (penicillin, ceftaroline
tetracycline, gentamicin and trimethoprim-sulfamethoxazole) and had a large number of genes
characteristic for antibiotic resistance.
Considering that little research has been published on MRSA within health care facilities
or on analysis of these bacteria from easily accessible environmental surfaces, the current study
seeks to analyze S. aureus strains from accessible health care centers in the greater New Haven
region.
Phenotypic Characteristics of MRSA
As touched on above, the testing of antibiotic resistant MRSA strains is typically
performed in a research setting. This is done for multiple reasons. Firstly, it is to confirm their
resistance against methicillin. However, laboratories typically use a substitute β-lactam antibiotic
(such as oxacillin or cefoxitin) instead of methicillin due to their longer shelf-life and lack of
commercially available methicillin. Secondly, testing of antibiotics outside of the β-lactams allows
for researchers to determine if MRSA strains are acquiring additional resistivity. Of specific
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interest is novel resistance to antibiotics with a different mechanism of action. Figure 1 in the
Appendix shows characteristic antibiotics of each mechanism of action.
In a 2015 study, Chang, Dhaliwal, Raju, and Kowalski (2015) tested wound cultures from
various hospital patients, isolated from January 1993 to November 2012. MRSA strains were
shown to be the most susceptible to the following antibiotics at the following percentages:
sulfamethoxazole (94.3%), bacitracin (89.3%), trimethoprim (88.5%), and gentamicin (86.1%).
In their study of clinically collected bacterial samples from patient wounds in Bangladesh,
Parvez, Ferdous, Rahman, and Islam (2018) tested the S. aureus bacteria for antibiotic resistivity.
Results are as follows: oxacillin (97%), gentamicin (85%), ceftazidime (76%), tetracyclin (68%),
chloramphenicol (66%), cirproflxacin (53%), and clindamycin (34%).
Kateete, et al. (2019) tested S. aureus from healthy Ugandan children for antibiotic
resistivity. All MRSA isolates were susceptible to vancomycin, linezolid, and clindamycin.
Resistances are as follows: trimethoprim-sulfamethoxazole (73.3%), erythromycin (75.6%),
chloramphenicol (60%), gentamicin (55.6%), and ciprofloxacin (35.6%).
Genotypic Characteristics of MRSA
In addition to phenotypic analysis, a bacteria’s genome can be utilized to help determine
its resistivity. The presence of a gene can be indicative of a bacterial strain’s resistance to
antibiotics, as the gene would encode for a protein which can combat the antibiotic’s effects on
the cell.
MRSA strains can produce antibiotic resistance against a certain family of antibiotics,
known as β-lactams, through an altered penicillin-binding protein. This altered protein has a
decreased affinity for most β-lactam antibiotics, as the active site conformation is not conducive
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to the characteristic molecular structure of these chemicals. The penicillin-binding protein (PBP)
is encoded by an acquired gene, mec. This gene is carried on the mobile staphylococcal cassette
chromosome mec, or SCCmec (Katayama, Ito, & Hiramatsu, 2000).
SCCmec elements are classified into a system of types and subtypes, defined by the mec
gene complex and ccr gene complex. A gene complex includes its defining gene and other genetic
elements related to the function and transcription of the gene. While the mec gene complex is
responsible for β-lactam resistance, the ccr gene complex is responsible for mobility of the
SCCmec within and between genomes.
The ccr gene complex may contain three distinct genes: ccrA, ccrB, and ccrC. Each gene
has its own allotypes, variants of the original with only small differences that do not have a large
impact on its function. Figure 2 shows the relationship between the ccr gene variants.
The ccr complex is typed according to which genes are present. Types 1-4 carry one ccrA
and one ccrB gene and are distinguished by which allotype is present, while type 5 carries only
ccrC gene(s). (International Working Group on the Classification of Stphylococcal Cassette
Chromosome Elements, 2009) The ccr genes can be detected by PCR analysis by utilizing primers
specific to the gene/allotype in question.
The mec gene complex generally consists of the mecA gene and variants of other
regulatory genes and insertion sequences. The variants of the gene complex are distinguished
only by the surrounding genetic elements, and are distinguished into classes based on their
presence, orientation, and length. The variants are identified as different classes: Class A, Class
B, Class C, and Class D. (International Working Group on the Classification of Stphylococcal
Cassette Chromosome Elements, 2009) There has also been a recently reported Class E, which

9
contains the mecC gene in place of the mecA gene. Figure 3 shows the classes of the mec gene
complex, along with some sub-classes.
The SCCmec region is a transposable element, meaning it can be inserted within a genome
and change its position. The vast majority of all known MRSA strains are inserted within the orfX
gene, a gene conserved among all Staphylococci (Hiramatsu, et al., 2013). With MRSA strains, the
orfX gene is essentially split, with the original genetic sequence conserved. From this, researchers
can easily isolate, amplify, and analyze the entirety of the SCCmec region by knowing its
preceding and succeeding genetic sequences (the split orfX genetic sequence).
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Methodology
Clinical Sample Collection
Universities who were willing to participate in this study are the University of New Haven
(West Haven, CT), Quinnipiac University (Hamden, CT), Sacred Heart University (Bridgeport, CT),
Bridgeport University (Bridgeport, CT), and Trinity College (Hartford, CT). Universities are
addressed by a randomly assigned number (Location 0, Location 1, etc.), so as to not link a specific
school to isolated strains, and all other future results.
Five samples were gathered from a random patient exam room at each health center.
Since room set up differed at each university, the samples were taken from and labeled as
follows: two countertop or table samples, one sink sample, one floor or floor corner sample, and
one exam bed sample.
All environmental swabs were performed over the course of two weeks, in mid to late
October 2019. Samples were collected in the following manner. A sterile cotton swab was
moistened in a 0.9% saline solution. Immediately after, it was swabbed on a sample collection
area and placed into the micro centrifuge tube containing the saline. Due to cotton swab length,
a portion of the swab stick was cut with a pair of sterile scissors, so that the cotton end could be
secured within the tube. After all samples were collected from a location, the tubes were sealed
in a plastic bag and stored in cool, refrigerated environments until transfer to the University of
New Haven laboratory space.
All tubes were labeled after securing of the swab, in a way to ensure university anonymity
from results. Two numbers were written on each tube. The first number corresponds to the
location number assigned to the university. The second number corresponds to the sample
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collection area from which it originated. Table 1 in the Appendix shows these number
designations. For example, the floor sample from Location 3 was labeled with the two-digit
number 34, and the sink sample from Location 0 was labeled with the number 03.
Environmental Control Sample Collection
In addition to the above clinical samples, swabs and samples were taken from various
environmental locations around the University of New Haven’s West Haven campus. Thirteen
samples came from buildings and areas commonly found on a college campus that are regularly
trafficked by student, faculty, and staff. Two additional soil samples were collected. All fifteen
samples were collected within a two-day period in early February 2020.
The first thirteen samples from various buildings across campus were collected via the
same procedure used for the clinical samples. After collection, the tubes were labeled with
number 100-113, based on collection order. For the two soil samples, a 50mL Eppendorf tube
was used to collect approximately 30mL of soil from each location. These were labeled as samples
114 and 115. Table 2 shows the number assignments for all environmental control samples.
The soil samples were prepared and diluted prior to initial mannitol salt agar (MSA)
plating. First, 1g of soil was diluted in 10mL of 0.9% saline. This was deemed the original soil
solution (hereby referred to as the undiluted solution). Aliquots from the undiluted solution were
extracted to create five diluted solutions, 1:1, 1:2, 1:4, 1:6, and 1:10 dilutions by volume,
respectively. Each solution was then transferred to a microcentrifuge tube labeled with the
sample number and corresponding dilution concentration (0 for undiluted, 1:1, 1:2, etc.)
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Identification of S. aureus strains
A loopful of inoculum from the saline solution of each micro centrifuge tube was streaked
onto a portion of a Mannitol Salt Agar plate. After streaking of all samples, all MSA plates were
incubated at 30°C for 30 hours. Those samples which produced no bacteria growth or little
growth with no mannitol fermenting bacteria were excluded from all further testing.
One area of mannitol fermenting bacterial growth from each pertinent sample was
streaked to single colony on individual MSA plates. For Samples 114 and 115 (the soil samples),
one area of mannitol fermenting bacterial growth from only the 1:10 dilution was streaked to
single colony. After 24 hours of incubation, a single mannitol fermenting colony was streaked
onto another MSA plate. These final MSA plates were used to obtain bacteria for subsequent
biochemical testing.
First, bacteria were streaked across DNase plates and incubated at 30°C for 20 hours.
Plates were then flooded with a 0.1% Toluidine Blue solution and allowed to incubate again for
1.5 hours. Plates were examined for color change, indicating DNase activity. Next, bacteria from
the final MSA plates were streaked across a microscope slide. A pure H2O2 solution was dropped
on the slide, with any gas formation noted as catalase activity. Then, bacteria were streaked onto
filter paper placed within a plate. The bacteria were then soaked with Remel’s BactiDrop™
OXIDASE testing solution. Blue/purple color change was noted as positive oxidase activity, as per
the manufacturer’s instructions. Finally, tubes containing 0.3mL of 0.1% reconstituted rabbit
serum were inoculated with sample bacteria and incubated at 30°C for 3 hours.
Solidification/coagulation of solution within the tube was recorded as positive coagulase activity.
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Results
Clinical Samples
Initial plating of the clinical samples revealed six mannitol positive bacteria from samples
04, 05, 11, 14, 23, and 45, all with moderate areas of growth. The rest of the nineteen samples in
this group had no bacterial growth. Figures 4 – 10 show these initial MSA plates. Isolation to
single colony for the six samples was successful, with clearly positive mannitol fermentation
through each stage.
The first round of DNase testing for the six clinical samples yielded positive results.
However, these results were not definitive due to poor execution of the plate flooding technique
used to apply the pH indicator. After adjustment to the technique, the second round of DNase
testing provided more definitive results. All six tested isolates showed clear pH indicator color
change from blue to green-yellow, the sign of positive DNase activity. Figures 11 – 16 show these
second round DNase plates.
Initial catalase testing of the six clinical samples were weakly positive, with only moderate
to low bubble formation. Subsequent testing utilizing hydrogen peroxide stored in a dark
environment provided the large bubble formation seen in Figures 17 – 19. All six samples were
catalase positive.
Oxidase testing on the filter paper proved effective, with all six clinical isolates showing
no color change to the reagent. Figures 20 – 22 show these results.
The two rounds of tube coagulase testing resulted in minimal clumping; the media did not
fully solidify after incubation. Figures are not available due to presumed third round of testing
(See “Shutdown” section of Discussion below).
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Overall, six of the 25 samples from the clinical group were mannitol fermenting, and had
subsequent biochemical testing fully consistent with S. aureus (DNase positive, oxidase negative,
catalase positive, and coagulase positive).
Environmental Samples
Initial plating of these samples revealed three mannitol positive bacteria from samples
103, 106, and 112. There was only one large colony from samples 106 and 112, while sample 103
had many small colonies. In addition, all dilutions of samples 114 and 115 contained strong
mannitol positive growth. These plates were colored yellow and fully scattered with bacterial
colonies. Samples 100 – 102, 104, 105, 107 – 111, and 113 showed no growth on the MSA plates.
Figures 23 – 34 in the Appendix show all initial environmental plates.
The first round of DNase testing again provided nondefinitive results due to the plate
flooding technique. Figures 35 – 39 show the results from the second round of DNase plates after
incubation with the pH indicator. The results from these were not ideal but show a clear color
change with all six samples.
Again, catalase testing was initially weakly positive for all samples. Figures 40 – 44 in the
Appendix shows these results. The second round of tests done with properly stored hydrogen
peroxide resulted in abundant bubble formation for all five isolates.
Oxidase testing again proved effective with the environmental samples. Four strains were
negative. Only the isolate from sample 114 was oxidase positive, with a clear purple change over
the bacteria seconds after the addition of the reagent. Figures 45 – 49 show these results.
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Tube coagulase testing for samples 103, 106, 112, and 115 were weakly positive with
limited clumping after incubation. Sample 114 had no visible clumping. No figures were obtained
due to another anticipated round of testing.
Overall
Six out of the 25 clinical samples contained mannitol-positive bacteria, all of which were
likely S. aureus based on the available metabolic testing. Only samples from Location 3 yielded
no bacteria growth on MSA plates. Five out of the 16 environmental samples contained mannitolpositive bacteria. Only one of these strains was not suggested to be S. aureus. The isolate taken
from sample 114 was oxidase positive and coagulase negative. As it was catalase positive, it is
most likely another Staphylococcus sp. but not of the species S. aureus.
24% of clinical samples contained S. aureus bacteria. 25% of environmental samples
contained S. aureus bacteria.
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Discussion
Obstacles
Initial timeline of the research was delayed, due to difficulties securing locations.
Although university health care centers were not the primary target for sample collection,
universities were the only institution willing to accept the proposal. The unanticipated additional
contact hours resulted in an initial sample collection date of October 18 th, 2019 instead of the
originally planned early to mid-September window.
Results from initial sample streaking proved effective. Abundant mannitol positive
bacterial growth was clear, even when limited to a fraction of the agar plate. This provided
sufficient reasoning that lack of growth or mannitol positive growth in negative quadrants was
not due to poor technique or potential bacterial competition.
The limited number of mannitol positive strains within the clinical isolates was
unexpectedly low, as environmental studies within the field tend to yield high percentages of S.
aureus isolates. This may be due to either good health center disinfection procedures or the
disparity between first world health care procedures (the currently study isolates) and thirdworld health care procedures (where all current environmental isolate studies are done).
Furthermore, the lower than anticipated S. aureus isolates from the environmental samples may
provide an additional reason for the lower yield in the clinical samples. If there is less S. aureus
in the environment than anticipated, then fewer of these bacteria can be transferred into the
health centers. This is corroborated by the similar S. aureus percentage among both groups.
The DNase plate results were the most subjective results obtained. This was due to the
inconsistencies that came with flooding the plates with pH indicator solution. Small pooling of
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the solution on the plate resulted in areas ranging from blue to green on the plate. As such, an
area of green color surrounding a section of bacterial growth was recorded as positive. Even after
adjustments to combat this, including controlled pouring of smaller amounts of solution, level
setting of plates, and use of a sturdy board within the grated incubation chamber, pooling can
still be seen on some of the DNase plates photographed.
Oxidase tests could not be performed in duplicate due to a lack of time (see Shutdown
section below). Once a procedure that produced clear results was found, the tests could not be
duplicated before laboratory shutdown.
Coagulase test results were not photographed due to the shutdown, as well. After initial
results for the environmental samples came back positive, preparations were underway to repeat
the test for all mannitol positive samples (including those from the clinical group). It was this
repeat test that would be photographed. Unfortunately, the laboratory shut down prior to the
execution of the replicate coagulase test.
Shutdown
The University of New Haven decided on March 9th, 2020 to suspend all in-person learning
activities and send all on-campus students home early, for a full 2 weeks, before the beginning
of the scheduled Spring Break. On Monday March 16 th, 2020, the University decided to move to
remote learning for the remainder of the Spring 2020 semester. This included the closure of all
on-campus laboratories.
For this reason, the original aims of this research could not be completed, which included
further phenotypic testing of the isolated bacterial strains to determine antibiotic resistance and
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preliminary genetic investigation of the bacteria. This was instead supplemented by additional
literature review, especially in the genetics of MRSA bacteria (see Introduction above).
Planned Future Methodology
Firstly, completion of the replicate oxidase and coagulase testing on the 11 isolates would
have taken place. Then, antibiotic resistance tests via disc-diffusion procedure would have been
performed with six different antibiotics: Penicillin, Cefoxitin (a β-lactam antibiotic used in place
of Methicillin for laboratory testing purposes), Vancomycin, Tetracycline, Erythromycin, and
Sulfamethoxazole-Trimethoprim. Finally, DNA isolated from all S. aureus strains would have
undergone PCR amplification with primers designed to target characteristic genes of the SCCmec
region. Ideal primers would include those for the orfX, mecA, and ccrC genes. (Raji, et al., 2016)
(Abdolmaleki, Mashak, & Dehkordi, 2019) (Hiramatsu, et al., 2013) Table 5 shows selected
primers for this proposed PCR tetsing.
The sequencing of the entire SCCmec region would not be done, due to length of the
region. Instead, a small region following the start of the orfX gene would be sequenced, to ensure
that the transposable region is present in the bacterial genome. In addition, sequencing of any
potential mecA and ccrC genes would be done, as these are the most common variants.
Overall, the planned testing would indicate whether the isolated S. aureus strains were
methicillin resistant. The comparison of MRSA presence between the environmental control and
clinical isolates would indicate whether the health centers were taking enough action in their
disinfection and cleaning to prevent the transmission of the bacterial pathogen. In addition,
MRSA findings from the environmental controls could provide further evidence of the prevalence
of the bacteria within our society. The genetic test results would give some indication of the
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pathogenicity of the strains isolated. In addition, they could provide some measure of
relationship between the strains. A closer taxonomic relationship would be an indication of
limited MRSA presence within the tested areas, as they are more likely to have come from the
same initial bacterium.
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Appendix
Explanatory Tables and Figures
Table 1: Labeling number assignments for each collection area
Sample Collection Area

Assigned Labeling Number

Countertop or Table - 1

1

Countertop or Table - 2

2

Sink

3

Floor / Floor Corner

4

Exam Bed

5

Table 2: Labeling number assignments for all environmental control samples
Sample Collection Area

Assigned Labeling Number

Dining Hall Plate

100

Dining Hall Tables

101

Dining Hall Silverware

102

Dining Hall Floor

103

Dormitory Door Handles

104

Dormitory Floor

105

Classroom Floor

106

Classroom Desk

107

Classroom Computer

108

Library Desk

109

Library Computer

110

Library Floor

111

Outdoor Cement Walkway

112

Student Lounge Furniture

113

Soil Sample 1 – Heavily Trafficked Mulch-Based Soil

114

Soil Sample 2 – Low Trafficked Vegetated Land

115
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Table 3: Results of Biochemical Tests for all clinical samples, with N/A indicating that the test
was not performed with the corresponding sample and multiple symbols indicating the results
for all replicate tests done

Sample
Number
01
02
03
04
05
11
12
13
14
15
21
22
23
24
25
31
32
33
34
35
41
42
43
44
45

Mannitol
Fermentation
(+/-)
+++
+++
+++
+++
+++
+++

DNase
Activity
(+/-)

Oxidase
Activity
(+/-)

Catalase
Activity
(+/-)

Coagulase
Activity
(+/-)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

++
++
++

-

++
++
++

++
++
++

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

++

-

++

++

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

++

-

++

++

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

++

-

++

++
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Table 4: Results of Biochemical Tests for all environmental control samples, with N/A indicating
that the test was not performed with the corresponding sample and multiple symbols
indicating the results for all replicate tests done

Sample
Number
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115

Mannitol
Fermentation
(+/-)
+++
+++
+++
+++
+++

DNase
Activity
(+/-)

Oxidase
Activity
(+/-)

Catalase
Activity
(+/-)

Coagulase
Activity
(+/-)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

++

-

++

+

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

++

-

++

+

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

++

-

++

+

N/A

N/A

N/A

N/A

++
++

+
-

++
++

+

Table 5: Planned primer sequences

Gene Name and Primer Direction

Primer Sequence

orfX forward

GAGAAATATTGGAAGCAAGCC

orfX reverse

CGCATAATCTTAAATGCTCTG

mecA forward

CTCATATAGCTCATCATACACTTTACC

mecA reverse

CACTTATTTTAATAGTTGTAGTTGTCGG

ccrC forward

CAGTAATGTCAAGATGTCGATGAATGC

ccrC reverse

CCGTCGACATACCATATTATTGCC
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Figure 1: Mechanism of action of antibiotics (Kapoor, Saigal, & Elongavan, 2017)
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Figure 2: Relationships and naming conventions for ccr genes. Pairwise identity percentages can
be thought of as percentages of relation, with the higher percentage representing a closer
relationship. (International Working Group on the Classification of Stphylococcal Cassette
Chromosome Elements, 2009)
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Figure 3: mec gene complex variants. (Lakhundi & Zhang, 2018)
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Figures of Experimental Results

Figure 4: Initial MSA plate, including samples 01, 02, 03, and 04 (from top left to bottom right,
respectively)

Figure 5: Initial MSA Plate, including samples 05, 11, 12, and 13 (from top left to bottom right,
respectively)
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Figure 6: Initial MSA Plate, including samples 14, 15, 21, and 22 (from top left to bottom right,
respectively)

Figure 7: Initial MSA Plate, including samples 23, 24, 25, and 31 (from top left to bottom right,
respectively)
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Figure 8: Initial MSA Plate, including samples 32, 33, 34, and 35 (from top left to bottom right,
respectively)

Figure 9: Initial MSA Plate, including samples 41, 42, 43, and 44 (from top left to bottom right,
respectively)
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Figure 10: Initial MSA Plate, including sample 45

Figure 11: DNase Plate of Sample 04 after incubation with pH indicator solution
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Figure 12: DNase Plate of Sample 05 after incubation with pH indicator solution

Figure 13: DNase Plate of Sample 11 after incubation with pH indicator solution
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Figure 14: DNase Plate of Sample 14 after incubation with pH indicator solution

Figure 15: DNase Plate of Sample 23 after incubation with pH indicator solution
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Figure 16: DNase Plate of Sample 45 after incubation with pH indicator solution

Figure 17: Catalase test results for Samples 04 and 05
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Figure 18: Catalase test results for Samples 11 and 14

Figure 19: Catalase test results for Samples 23 and 45
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Figure 20: Oxidase test results for Samples 04 and 05

Figure 21: Oxidase test results for Samples 11 and 14
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Figure 22: Oxidase test results for Samples 23 and 45

Figure 23: Initial MSA Plate, including samples 100, 101, and 102
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Figure 24: Initial MSA Plate, including samples 103, 104, and 105

Figure 25: Initial MSA Plate, including samples 106 and 107
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Figure 26: Initial MSA Plate, including samples 108 and 109

Figure 27: Initial MSA Plate, including samples 110, 111, and 112

38

Figure 28: Initial MSA Plate, including sample 113

Figure 29: Initial MSA Plate, including undiluted and 1:1 dilution of Sample 114
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Figure 30: Initial MSA Plate, including 1:2 and 1:4 dilutions of Sample 114

Figure 31: Initial MSA Plate, including 1:6 and 1:10 dilutions of Sample 114
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Figure 32: Initial MSA Plate, including undiluted and 1:1 dilution of Sample 115

Figure 33: Initial MSA Plate, including 1:2 and 1:4 dilutions of Sample 115
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Figure 34: Initial MSA Plate, including 1:6 and 1:10 dilutions of Sample 115

Figure 35: DNase Plate of Sample 103 after incubation with pH indicator solution
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Figure 36: DNase Plate of Sample 106 after incubation with pH indicator solution

Figure 37: DNase Plate of Sample 112 after incubation with pH indicator solution
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Figure 38: DNase Plate of Sample 114 after incubation with pH indicator solution

Figure 39: DNase Plate of Sample 115 after incubation with pH indicator solution
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Figure 40: Catalase Test results for Sample 103

Figure 41: Catalase Test results for Sample 106

45

Figure 42: Catalase Test results for Sample 112

Figure 43: Catalase Test results for Sample 114
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Figure 44: Catalase Test results for Sample 115

Figure 45: Oxidase Test results for Sample 103
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Figure 46: Oxidase Test results for Sample 106

Figure 47: Oxidase Test results for Sample 112
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Figure 48: Oxidase Test results for Sample 114

Figure 49: Oxidase Test results for Sample 115
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